Anomalous mitral arcade is a rare congenital heart disease characterized by the presence of a fibrous or fibromuscular arch-shaped structure extending between the mitral leaflets or between chordae tendineae, leading to obstruction of the mitral orifice. Although it may morphologically resemble an accessory valvular band, it is distinguished by its embryological origin and dynamic behavior.
This condition typically presents in childhood, but in mild cases it may remain undetected until adolescence or adulthood. It can occur as an isolated defect or in association with other congenital anomalies, including ventricular septal defect, aortic coarctation, or hypoplastic left heart syndrome. Its clinical relevance lies in the potential to cause progressive obstruction of left ventricular filling, mimicking a valvular mitral stenosis.
The etiologic causes of anomalous mitral arcade are attributed to abnormal embryological development of the endocardial cushion and the mitral valve apparatus. Normally, between the 5th and 8th weeks of gestation, the mitral leaflets and subvalvular structures (chordae tendineae and papillary muscles) develop from the mesenchymal tissue of the endocardial cushions and the atrioventricular canal.
Proper delamination and cellular apoptosis lead to the separation of the leaflets from the ventricular wall. A defect in this process, due to persistent mesenchymal adhesion, can result in residual fibrous bands extending between cusps, chordae, or papillary muscles, forming an arch-like structure that partially or completely traverses the mitral orifice.
Experimental studies and histological observations suggest that such alterations may arise from dysfunctions in the molecular pathways involved in valvulogenesis, including the Notch, TGF-β, and BMP signaling pathways, which regulate mesenchymal differentiation and valvular remodeling.
Risk factors have not been clearly identified, but cases have been reported in association with complex genetic conditions, chromosomal syndromes (such as 22q11 microdeletion or trisomy 21), and connective tissue disorders, suggesting a possible syndromic predisposition in some subgroups. However, in the majority of patients, the anomaly appears sporadic and isolated, indicative of a likely multifactorial pathogenesis involving interaction between genetic predisposition and intrauterine environmental factors.
The anatomic pathogenesis involves the presence of a fibrous or fibromuscular structure interposed between the mitral leaflets or chordae tendineae, forming a physical barrier to diastolic flow.
Three main morphological variants can be distinguished:
The resulting pathophysiology is similar to that of functional mitral stenosis. During diastole, the anomalous structure limits the opening of the mitral orifice, causing:
The obstruction may be fixed (if the structure is rigid and immobile) or dynamic (if passively stretched during diastolic flow). In neonates with severe forms, it may cause early heart failure and pulmonary hypertension, whereas in older children it may present with exertional dyspnea, fatigue, or supraventricular arrhythmias due to atrial overload. The severity of the clinical picture depends on the morphology of the arcade and the size of the residual orifice.
The clinical presentation of anomalous mitral arcade is extremely heterogeneous and depends on multiple factors: the degree of mitral obstruction, the morphological configuration of the arcade, the age at presentation, and the possible presence of associated congenital heart defects. The course may be completely asymptomatic or may cause progressive heart failure in the first months of life. In mild cases, the condition may remain silent until adolescence or adulthood, where it manifests with nonspecific symptoms that may initially be attributed to other conditions.
In neonates and infants with severe obstruction, clinical onset is early and characterized by symptoms of left-sided heart failure. The underlying pathophysiology is related to increased left atrial pressure secondary to reduced mitral valve opening, leading to pulmonary venous congestion and increased respiratory workload.
The clinical picture includes:
In preschool or school-age children, symptoms may be more subtle and insidious. Patients with partial obstruction gradually develop symptoms related to reduced left ventricular compliance and atrial overload.
In these cases, the clinical picture overlaps with that of mild-to-moderate mitral stenosis:
In adolescents and young adults, symptoms are often misinterpreted or attributed to anxiety or low exercise tolerance. In some cases, the anomaly may present with paroxysmal or persistent atrial fibrillation, representing a late complication of chronic atrial hypertension. Other possible signs include:
On physical examination, findings depend on the severity of the obstruction. In significant cases, auscultation may reveal:
It should be noted that in the presence of associated defects (e.g., ventricular septal defect or hypoplastic left heart syndrome), the clinical manifestations of anomalous mitral arcade may be masked or altered. In such contexts, diagnosis requires careful correlation of clinical and echocardiographic data.
Finally, in subclinical cases, diagnosis may be suggested by indirect instrumental findings: cardiomegaly on chest X-ray, signs of left atrial enlargement on ECG (mitral P wave), or diastolic dysfunction observed on pulsed Doppler imaging.
Diagnosing anomalous mitral arcade requires a high index of clinical suspicion, particularly in pediatric patients presenting with symptoms suggestive of mitral stenosis in the absence of obvious valvular anomalies on physical examination. The condition is often underdiagnosed or mistaken for other forms of congenital mitral obstruction, due to its rarity and the variability of its clinical presentation. The diagnostic pathway is based on a multimodal assessment beginning with clinical suspicion supported by compatible signs and symptoms, followed by echocardiographic confirmation and, in uncertain or complex cases, advanced imaging.
First-line diagnostic investigations include:
The definitive diagnosis is established by transthoracic echocardiography, which allows:
In patients with limited acoustic windows or older children, transesophageal echocardiography (TEE) may be required to confirm the diagnosis, particularly if a partial form is suspected or differentiation from other accessory structures such as aberrant chords, supravalvular membranes, or postsurgical residual tissue is needed. TEE provides high-resolution imaging of the mitral valve plane and subvalvular apparatus, enabling detailed evaluation of arcade morphology and mobility.
In selected complex cases, cardiac MRI may be indicated for more precise anatomical characterization, useful to:
Multislice cardiac CT is rarely used, but may aid in uncooperative patients or pre-surgical planning, allowing precise assessment of the mitral complex anatomy and its relationship with adjacent intrathoracic structures.
Finally, in cases where surgical correction is planned, cardiac catheterization may be useful for direct measurement of the trans-mitral pressure gradient and evaluation of pulmonary vascular resistance, particularly in patients with pulmonary hypertension or symptoms disproportionate to echocardiographic findings.
Accurate identification of the structure and its functional impact is essential not only for diagnosis, but also for guiding therapeutic choices and surgical indication.
The therapeutic management of anomalous mitral arcade depends on the degree of valvular obstruction and the presence of symptoms or signs of hemodynamic compromise. In asymptomatic patients with a low-grade transvalvular gradient and preserved left ventricular function, periodic clinical and echocardiographic follow-up is indicated to monitor progression of the obstruction and the possible onset of symptoms. Conservative treatment is reserved exclusively for mild and stable forms.
Surgical treatment is the standard of care in clinically significant cases. Surgery is indicated in the presence of:
The procedure consists of surgical resection of the fibromuscular arcade, via a left atrial approach under cardiopulmonary bypass. The goal is to remove the abnormal structure without damaging the chordae tendineae, valve leaflets, or papillary muscles. In selected cases, additional mitral valve repair may be required to restore optimal valve anatomy. Mitral valve replacement is a last-resort option, reserved for patients with associated valvular dysplasia or failed repair.
Postoperative outcomes are generally favorable. Removal of the mechanical obstruction results in rapid symptom regression and normalization of mitral diastolic flow. Operative mortality is very low (<1% in specialized centers), and preservation of the native valvular apparatus ensures excellent long-term function.
Prognosis mainly depends on the timing of surgery. Patients operated on early, before the development of pulmonary hypertension or advanced atrial remodeling, have an excellent clinical course, with full functional recovery and return to normal physical activity. Annual echocardiographic follow-up is recommended to monitor for possible late changes, such as secondary mitral regurgitation or signs of restenosis.
Conversely, in untreated patients or those undergoing delayed intervention, the natural history may progress toward chronic diastolic heart failure, irreversible pulmonary hypertension, and cardiac rhythm instability. In such cases, the prognosis is more guarded and requires multidisciplinary management.
Complications associated with anomalous mitral arcade may result either from the natural evolution of the disease, in the absence of treatment, or from the outcomes of corrective surgery. The likelihood and severity of such events depend largely on the promptness of diagnosis, the extent of mitral obstruction, and the quality of therapeutic management. In mild, promptly recognized forms, complications are rare; conversely, in untreated or late-operated patients, the risk of progressive hemodynamic deterioration is high.
During the natural course of the malformation, the most common and earliest complication is post-capillary pulmonary hypertension, caused by persistently elevated left atrial pressure and retrograde transmission to the pulmonary venous circulation. Over time, this leads to vascular remodeling of the pulmonary arterial bed, with increased resistance and possible irreversibility. Concurrently, the left atrium tends to undergo progressive dilation in response to chronic pressure and volume overload: this forms the anatomical substrate for the development of supraventricular arrhythmias, particularly atrial flutter and fibrillation. Once established, these arrhythmias further worsen diastolic dysfunction and increase the risk of thromboembolic events, especially in patients with markedly enlarged atria or impaired contractile function.
Another major pathophysiological mechanism involves the development of chronic diastolic heart failure. Reduced left ventricular compliance, secondary to valvular obstruction, limits end-diastolic filling and compromises stroke volume, causing fatigue, dyspnea, and signs of peripheral hypoperfusion, especially in neonates and infants. In these patients, low cardiac output may manifest with hypotension, poor growth, relative cyanosis, and reduced exercise tolerance. In advanced cases, progressive deterioration of ventricular performance and global clinical worsening are observed.
Even after corrective surgery, complications may arise, although the experience of highly specialized centers has significantly reduced their incidence. Residual mitral regurgitation, due to inadvertent injury of valvular structures during arcade resection, is among the most common. It may present immediately after surgery or develop progressively over time, requiring regular echocardiographic monitoring to assess the need for reintervention. Other postoperative complications include recurrence of mitral obstruction due to reactive fibrous tissue formation or incomplete resection of the anomalous structure, and persistence of atrial arrhythmias in patients with preoperative marked left atrial dilation.
A rare but noteworthy possibility is injury to the atrioventricular conduction system, especially when the arcade is located near the interatrial septum. This may lead to complete AV block and necessitate permanent pacemaker implantation. Finally, in patients with persistent atrial fibrillation or high embolic risk, the need for anticoagulant or antiplatelet therapy should be carefully assessed, tailored to the hemodynamic profile and individual thrombotic risk.
Overall, the probability of complications can be drastically reduced through early diagnosis, well-considered surgical indication, and structured long-term follow-up. A multidisciplinary approach involving pediatric cardiologists, cardiac surgeons, and advanced imaging specialists is essential to ensure favorable outcomes and preserve the patient's quality of life over time.